ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 78 filers reported holding ODONATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $82,000 | -53.7% | 60,901 | 0.0% | 0.00% | – |
| Q3 2021 | $177,000 | -75.0% | 60,901 | -70.0% | 0.00% | – |
| Q2 2021 | $709,000 | +189.4% | 202,963 | +183.5% | 0.00% | – |
| Q1 2021 | $245,000 | -82.7% | 71,582 | -2.9% | 0.00% | -100.0% |
| Q4 2020 | $1,416,000 | +50.6% | 73,712 | +5.3% | 0.00% | 0.0% |
| Q3 2020 | $940,000 | +234.5% | 70,012 | +954.6% | 0.00% | – |
| Q2 2020 | $281,000 | +198.9% | 6,639 | +94.9% | 0.00% | – |
| Q1 2020 | $94,000 | -70.7% | 3,407 | -65.8% | 0.00% | – |
| Q4 2019 | $321,000 | +58.1% | 9,952 | +27.1% | 0.00% | – |
| Q3 2019 | $203,000 | -7.3% | 7,833 | +30.5% | 0.00% | – |
| Q2 2019 | $219,000 | +17.7% | 6,004 | -29.4% | 0.00% | – |
| Q1 2019 | $186,000 | +51.2% | 8,505 | -3.3% | 0.00% | – |
| Q4 2018 | $123,000 | -78.0% | 8,795 | -69.5% | 0.00% | – |
| Q3 2018 | $558,000 | +5.3% | 28,849 | +19.9% | 0.00% | – |
| Q2 2018 | $530,000 | +188.0% | 24,058 | +175.4% | 0.00% | – |
| Q1 2018 | $184,000 | – | 8,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
| Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
| Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
| Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
| RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
| Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
| Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
| Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
| SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |